Search hospitals
>
California
>
Sacramento
University of California, Davis, Medical Center
Claim this profile
Sacramento, California 95817
Global Leader in Duchenne Muscular Dystrophy
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Pulmonary Arterial Hypertension
Conducts research for HIV Infection
1080 reported clinical trials
95 medical researchers
Summary
University of California, Davis, Medical Center is a medical facility located in Sacramento, California. This center is recognized for care of Duchenne Muscular Dystrophy, Lung Cancer, Cancer, Pulmonary Arterial Hypertension, HIV Infection and other specialties. University of California, Davis, Medical Center is involved with conducting 1,080 clinical trials across 1,255 conditions. There are 95 research doctors associated with this hospital, such as Edward J. Kim, Jonathan W. Riess, Mamta Parikh, and Joseph M. Tuscano.
Area of expertise
Duchenne Muscular Dystrophy
University of California, Davis, Medical Center has run 49 trials for Duchenne Muscular Dystrophy. Some of their research focus areas include:
Lung Cancer
University of California, Davis, Medical Center has run 44 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Edward J. Kim
University of California Davis Comprehensive Cancer Center
2 years of reported clinical research
Jonathan W. Riess
University of California Davis Comprehensive Cancer Center
6 years of reported clinical research
Mamta Parikh
University of California Davis Comprehensive Cancer Center
5 years of reported clinical research
Joseph M. Tuscano
University of California Davis Comprehensive Cancer Center
1 year of reported clinical research
Clinical Trials running at University of California, Davis, Medical Center
Lazy Eye
Breast Cancer
Age-Related Macular Degeneration
Huntington's Disease
Idiopathic Pulmonary Fibrosis
Seizures
Head and Neck Cancers
Bladder Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Dichoptic Treatment
for Lazy Eye
Participants eligible for the study will be randomly allocated (1:1:1) to receive either Luminopia dichoptic treatment while wearing optical correction if needed, Vivid Vision dichoptic treatment while wearing optical correction if needed, or continued optical correction alone if needed, with clinical assessments at 9- and 18-weeks post-randomization. At the 18-week primary outcome visit, participants who were randomly assigned to receive optical correction alone if needed with an IOD of 1 logMAR line (5 letters) or more, will be offered randomization to Luminopia or Vivid Vision dichoptic therapy and if they accept, followed forward with visits at 27- and 36-weeks post-randomization. The study will end for all other participants at 18 weeks.
Recruiting
2 awards
Phase 3
2 criteria
Patching Strategies
for Lazy Eye
A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to \<13 years of age.
Recruiting
2 awards
Phase 3
18 criteria
Dichoptic Treatment
for Lazy Eye
In children 4 to 7 years of age, to determine if treatment with 1 hour per day 6 days per week of watching dichoptic movies/shows wearing the Luminopia headset is non-inferior to treatment with 2 hours of patching per day 7 days per week with respect to change in amblyopic eye distance VA from randomization to 26 weeks.
Recruiting
2 awards
Phase 3
3 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of California, Davis, Medical Center?
University of California, Davis, Medical Center is a medical facility located in Sacramento, California. This center is recognized for care of Duchenne Muscular Dystrophy, Lung Cancer, Cancer, Pulmonary Arterial Hypertension, HIV Infection and other specialties. University of California, Davis, Medical Center is involved with conducting 1,080 clinical trials across 1,255 conditions. There are 95 research doctors associated with this hospital, such as Edward J. Kim, Jonathan W. Riess, Mamta Parikh, and Joseph M. Tuscano.
Where is University of California, Davis, Medical Center located?
**Directions to University of California, Davis Medical Center:** - From I-80 West, exit onto Stockton Blvd and turn right. - Turn left onto X Street to reach the hospital's main entrance.
Who should I call to ask about financial aid or insurance network?
**University of California, Davis Medical Center - Financial Assistance and Insurance Contact Information** **Financial Assistance:** - **Phone:** (916) 734-9200 or 1-800-551-9411 (Monday–Friday, 8:30 a.m. to 4:00 p.m.) - **Hand-Delivery Address:** Financial Clearance Department, 4301 X St., Suite 1P214, Sacramento, CA 95817 - **Mailing Address:** UC Davis Health Patient Billing, Attn: FA Program, PO Box 168015, Sacramento, CA 95816-9979 **Insurance and Billing:** - **Hospital Bill (Before Discharge):** Contact the Financial Clearance Department - **Hospital Bill (After Discharge), Doctors’ Fees, or Outpatient Services Bill:** Contact Patient Billing Customer Service - **Email:** hs-patientbilling@ucdavis.edu For the financial assistance policy and application, visit the UC Davis Health website.
What insurance does University of California, Davis, Medical Center accept?
The University of California, Davis, Medical Center accepts a range of insurance plans, such as PPOs and standard plans from Aetna, Beech Street, Anthem Blue Cross, Blue Shield, Cigna, Health Net, UC Blue & Gold, and United Healthcare. Health Net's UC Blue & Gold HMO plan also provides access to UC Davis Medical Center and UC Davis Health primary care providers and specialists. It is recommended to confirm the acceptance of your specific insurance plan by directly contacting the facility or consulting with your insurance provider.
What awards or recognition has University of California, Davis, Medical Center received?
The University of California, Davis, Medical Center, located in Sacramento, California, is renowned for its groundbreaking research. In 2022, it achieved a new milestone by securing $1.07 billion in external research funding. Additionally, in 2023, the California Institute for Regenerative Medicine (CIRM) supported its stem-cell research projects with over $36 million.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.